ScienceNot yet confirmed elsewhere1 publisher2 min readPublished
SW.2 accounts for about 21% of reported COVID infections heading into winter
SW.2 accounts for about 21 percent of reported COVID-19 infections, ahead of XFG at 16 percent, while positive tests rise in the UK, Europe and the US. UK health officials say current data do not link any of the watched variants to significantly more severe illness.
The Scientist · Science desk

What happened
- A routine COVID-19 test shows only whether the virus is present, and naming the variant takes genomic sequencing of the virus's genetic code.
- BA.3.2, an Omicron BA.3 lineage nicknamed Cicada, is near 2 percent of cases but carries mutations that make vaccine escape more likely, according to Respiratory Therapy.
- Discover says the rise is likely seasonal, driven by more indoor gatherings and fading immunity from the last vaccination.
Why it matters
- contradiction The CDC's declining national trend runs against rising US positivity and regional upticks, so how heavy the US season looks depends on which geography a reader checks.
- constraint Because shares come from sequencing only a fraction of positives, how precise the 2 percent BA.3.2 figure is depends on a sample size readers cannot check from this report.
- exposure People with immune-affecting conditions, some cancers, autoimmune disease or organ-system disease carry more risk as circulation and admissions climb, whichever variant leads.
Every variant share in this report is a fraction of sequenced samples. Agencies pull a percentage of positive clinical tests for genomic sequencing and follow variant trends from those [6]. The three variants named add up to about 39 percent of reported infections, which leaves roughly 61 percent spread across other lineages [13]. SW.2 is described as one of the most dominant strains globally [1]. Its lead over XFG, which has circulated internationally for about a year, is about 5 percentage points [2][14].
Discover's case for sequencing is that a variant profile helps agencies judge how well current medical tools work against what is spreading [10]. In this report the immune-escape flag goes on BA.3.2, the smallest of the three [3]. The report does not include vaccine-effectiveness data for any of them. For SW.2 and XFG, the evidence on hand is their case shares and a severity comparison from the UK [1][2][7]. So the two largest named variants are described by how common they are, and the one flagged for evading vaccine immunity sits at about 2 percent [3].
The severity picture comes from the UK Health Security Agency. It says current data do not show these variants causing significantly more severe illness than others in circulation [7]. It also reports hospitalizations climbing alongside circulation [8]. Those two findings sit together comfortably. Admissions that rise with infections are what more cases at unchanged per-case severity would produce, and Discover interprets the UK data as overall activity rising, with no single variant driving worse disease [12]. A hospital count that tracks a case count cannot separate volume from virulence on its own. That separation needs the variant-by-variant comparison the agency describes [7].
Discover calls the seasonal explanation likely: more time indoors, and immunity from the last vaccination wearing off [16]. I think that is the right default reading while the UK severity data stay flat [7]. If one lineage, BA.3.2 or another, starts to account for the growth, the sequenced share of positives is where it would show first [6][10].
What to watch
- WHO tracking of BA.3.2: a share climbing well above its current 2 percent would move vaccine escape to the center of the season.
- A UKHSA update tying any one variant to more severe illness, or showing admissions rising faster than infections.
- Whether the CDC's national COVID-19 trend turns upward to match the rising positivity reported for the US.
Clarity's read
What the record supports and how the coverage leans. The claims behind it follow.
Reality
- Evidence40
- Adoption
- Insufficient
- Hype gap+10
- Incentives
- Insufficient
- Confidence40
Claim ledger
Ranked by verification strength, evidence, and original report placement.
- [1]
The SW.2 variant accounts for around 21 percent of reported COVID-19 infections, making it one of the most dominant strains globally.
- [2]
XFG, the Stratus variant, accounts for 16 percent and has been around internationally for about a year.
- [3]
BA.3.2, also called Cicada and part of the Omicron BA.3 lineage, is at low case numbers (around 2 percent), but its mutation profile makes it more likely to evade vaccine immunity, according to Respiratory Therapy.
- [4]
The World Health Organization actively monitors BA.3.2's global appearance.
- [5]
A regular COVID-19 test shows whether the virus is present but not which variant; identifying the variant requires genomic sequencing of the virus's genetic code, as explained by Nebraska Medicine.
- [6]
Health experts pull a certain percentage of positive clinical tests for genetic testing to monitor variant trends in the community.
- [7]
Currently available data do not show that the variants mentioned are leading to significantly more severe illness compared with other circulating variants, according to the UK Health Security Agency.
- [8]
The UK Health Security Agency states that hospitalizations are increasing alongside COVID-19 circulation.
- [9]
The CDC reports elevated COVID-19 activity in some US regions but a declining trend nationally.
- [10]
Understanding a virus's variant profile allows public health agencies to prepare for how a disease spreads, how severely it affects the body, and how effective current medical tools are against it.
- [11]
People with conditions affecting the immune system, some cancers, autoimmune or inflammatory conditions, and diseases of several organ systems are more vulnerable to viral infections.
- [12]
Discover interprets the UK data as overall COVID-19 activity increasing generally, instead of one particular variant causing more severe infection.
- [13]
SW.2, XFG and BA.3.2 together account for about 39 percent of reported infections, leaving roughly 61 percent across other lineages.
- [14]
SW.2's share exceeds XFG's by about 5 percentage points.
- [15]
Positive COVID-19 tests are increasing in the United Kingdom, across Europe, and in the United States.
ReportedContestedSource: Discover Magazine2 sources— create a free account to open themView cited source - [16]
The current rise in COVID-19 cases is likely related to the change of seasons, as people gather indoors more and immunity from the last vaccination wanes.
Sources
1 independent publisher whose own reporting we read for this story.
Topics and entities
Follow any of these and your For You feed starts watching them — no settings page required.
Entities
- SW.2Follow
- XFGFollow
- BA.3.2Follow
- World Health OrganizationFollow
- UK Health Security AgencyFollow
- US Centers for Disease ControlFollow
- Nebraska MedicineFollow
- Discover MagazineFollow